Cost‐effectiveness of negative pressure wound therapy in patients with many comorbidities and severe wounds of various etiology
Authors:
- 18 October 2016
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 24 (6) , 1041-1058
Abstract
This study analyzed a cross-section of patients with severe chronic wounds and multiple comorbidities at an outpatient wound clinic, with regard to the cost-effectiveness and cost-benefit of negative pressure wound therapy (intervention) vs. no negative pressure wound therapy (control) at 1 and 2 years. Medicare reimbursement charges for wound care were used to calculate costs. Amputation charges were assessed using diagnosis-related groups. Cost-benefit analysis was based on ulcer-free months and cost-effectiveness on quality-adjusted life-years. Undiscounted costs, benefits, quality-adjusted life-years, undiscounted and discounted incremental net health benefits, and incremental cost-effectiveness ratios were calculated for unmatched and matched cohorts. There were 150 subjects in the intervention group and 154 controls before matching and 103 subjects in each of the matched cohorts. Time to heal for the intervention cohort was significantly shorter compared to the controls (270 vs. 635 days, p = 1.0 × 10−7, matched cohorts). The intervention cohort had higher benefits and quality-adjusted life-year gains compared to the control cohort at years 1 and 2; by year 2, the gains were 68–73% higher. In the unmatched cohorts, the incremental net health benefit was $9,933 per ulcer-free month at year 2 for the intervention; the incremental cost-effectiveness ratio was −825,271 per quality-adjusted life-year gained (undiscounted costs and benefits). For the matched cohorts, the incremental net health benefits was only $1,371 per ulcer-free month for the intervention, but the incremental cost-effectiveness ratio was $366,683 per quality-adjusted life-year gained for year 2 (discounted costs and benefits). In a patient population with severe chronic wounds and serious comorbidities, negative pressure wound therapy resulted in faster healing wounds and was more cost-effective with greater cost-benefits than not using negative pressure wound therapy. Regarding overall cost-effectiveness, the intervention was still expensive, but that is the reality amidst limited treatment options for such serious cases of chronic wounds.Keywords
Funding Information
- KCI, an Acelity Company
This publication has 15 references indexed in Scilit:
- Evaluation of Wound Care and Health-Care Use Costs in Patients with Diabetic Foot Ulcers Treated with Negative Pressure Wound Therapy versus Advanced Moist Wound TherapyJournal of the American Podiatric Medical Association, 2014
- Human skin wounds: A major and snowballing threat to public health and the economyWound Repair and Regeneration, 2009
- Early Intervention of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure in Trauma PatientsAdvances in Skin & Wound Care, 2009
- Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot woundsThe American Journal of Surgery, 2008
- A New Era of Pressure Ulcer Accountability in Acute CareAdvances in Skin & Wound Care, 2008
- An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcersJournal of Wound Care, 2008
- Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trialThe Lancet, 2005
- Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S.Diabetes Care, 2003
- Vacuum-Assisted Closure: A New Method for Wound Control and TreatmentAnnals of Plastic Surgery, 1997
- Vacuum-Assisted Closure: A New Method for Wound Control and TreatmentAnnals of Plastic Surgery, 1997